M&A Deal Summary

Frazier Healthcare Partners Acquires BioMatrix Specialty Pharmacy

On June 25, 2024, growth capital firm Frazier Healthcare Partners acquired life science company BioMatrix Specialty Pharmacy from ACON Investments and Triton Pacific Capital Partners

Acquisition Highlights
  • This is Frazier Healthcare Partners’ 17th transaction in the Life Science sector.
  • This is Frazier Healthcare Partners’ 46th transaction in the United States.
  • This is Frazier Healthcare Partners’ 1st transaction in Florida.

M&A Deal Summary

Date 2024-06-25
Target BioMatrix Specialty Pharmacy
Sector Life Science
Buyer(s) Frazier Healthcare Partners
Sellers(s) ACON Investments
Triton Pacific Capital Partners
Deal Type Secondary Buyout

Target

BioMatrix Specialty Pharmacy

Plantation, Florida, United States
BioMatrix Specialty's corporate headquarters in Plantation, Florida.
BioMatrix Specialty's corporate headquarters in Plantation, Florida.
BioMatrix Specialty Pharmacy offers a comprehensive pharmacy with a wide range of services across hemophilia, transplantation, specialty, and digital health technology solutions. BioMatrix Specialty Pharmacy is a provider for patients with blood disorders, organ transplants and other chronic and acute diseases and conditions. BioMatrix Specialty Pharmacy was founded in 2015 and is based in Plantation, Florida.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer
DESCRIPTION

Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.


DEAL STATS #
Overall 47 of 48
Sector (Life Science) 17 of 17
Type (Secondary Buyout) 9 of 10
State (Florida) 1 of 1
Country (United States) 46 of 47
Year (2024) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-12 Alcresta Therapeutics

Newton, Massachusetts, United States

Alcresta Therapeutics is a specialty pharmaceutical company focusing on discovering and developing a new generation of enzyme-based products that improve digestion and absorption of important nutrients. The company's lead program is a point-of-care, enzyme-based product that improves the bioavailability of long-chain fatty acids (such as DHA, EPA, and AA) for patients with impaired pancreatic output. Compromised pancreatic function is a complication of many diseases such as cystic fibrosis, chronic pancreatitis, and cancer as well as developmental immaturity, and Alcresta's products are aimed at meeting the nutritional needs of these patients. Alcresta Therapeutics was formed in 2011 and is based in Newton, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-15 DirectMed Imaging

Poway, California, United States

DirectMed Imaging is a provider of medical imaging aftermarket parts, systems, and field service solutions. DirectMed Imaging was founded in 2011 and is based in Poway, California.

Buy -

Seller(S) 2

SELLER

ACON Investments

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1996
PE ASSETS 7.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

ACON Investments is an international private equity firm that targets investments in the US, Europe, and Latin America. ACON's investment strategy covers 'opportunities at times of change - responding at points of inflection where value creation is possible'. Examples include businesses that serve the rapidly growing US Hispanic population, energy and energy service needs, businesses in need of operational help, and opportunities in Latin America resulting from economic deregulation and political liberalization. ACON's looks for companies where it can commit $20 to $150 million of equity capital. Target sectors include consumer products and services, distribution, business services and industrial manufacturing. ACON Investments was formed in 1996 and has offices in Washington DC; Houston, Texas; Los Angeles, California; and Madrid, Spain.


DEAL STATS #
Overall 28 of 31
Sector (Life Science) 2 of 2
Type (Secondary Buyout) 2 of 4
State (Florida) 3 of 3
Country (United States) 19 of 21
Year (2024) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-18 Vitalis

Bogota, Colombia

Vitalis is a manufacturer and wholesaler of generic injectable pharmaceuticals with production facilities in Colombia and Mexico. Vitalis is based in Bogota, Colombia.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-17 Contenur

Getafe, Spain

Contenur engages in the design, engineering and marketing of containers to the waste collection industry. The company provides all kinds of maintenance services to urban furnishing, ranging from container recycling to playground maintenance. Contenur was founded in 1985 and is based in Getafe (Madrid) and with international presence in Latam (Brazil, Colombia and Peru), Asia (Singapore) and Middle East, the company also has commercial teams and branches in the United Kingdom, France, Germany, Italy, Portugal, the Czech Republic, Poland and Morocco, as well as two manufacturing plants in Spain and Poland.

Sell -
SELLER

Triton Pacific Capital Partners

Los Angeles, California, United States

Category Private Equity Firm
Founded 1996
Size Small
Type Sector Agnostic
DESCRIPTION

Triton Pacific Capital Partners is a private equity firm focused on investing in US based small to mid-size growth companies. Triton looks to invest $5 to $15 million in companies generating $2 to $10 million of EBITDA. Sectors of interest include healthcare services, software, IT, business services, consumer products, light manufacturing, logistics, and value-added distribution. Prospective transaction situations include recapitalizations, management buyouts, growth capital financings, divestitures, and shareholder liquidity needs. Triton Pacific Capital Partners was formed in 1996 based in Los Angeles, California.


DEAL STATS #
Overall 9 of 9
Sector (Life Science) 2 of 2
Type (Secondary Buyout) 3 of 3
State (Florida) 1 of 1
Country (United States) 9 of 9
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-10 Integrated Pain Associates

Killeen, Texas, United States

Integrated Pain Associates is a medical services platform specializing in the treatment of musculoskeletal pain. Integrated Pain Associates help patients suffering from chronic pain improve their quality of life through cutting-edge treatments and surgical procedures. Integrated Pain Associates is based in Killeen, Texas.

Buy -